Third Rock Ventures II, L.P. Insider Trading $GBT Global Blood Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Third Rock Ventures II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).
Third Rock Ventures II, L.P. in Global Blood Therapeutics, Inc.
Trading Symbol: GBTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,475,191 shares
Current Value: $40,098,094
Latest Transaction: Jun 16 2017
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Third Rock Ventures II, L.P. in Global Blood Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,475,191 | 3.5 M to 2.5 M (-28.78 %) |
May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,475,191 | 4.5 M to 3.5 M (-22.35 %) |
May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Gift | G | 0.00 | 1,708 | 0 | 163,996 | 165.7 K to 164 K (-1.03 %) |
May 19 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Gift | G | 0.00 | 50,000 | 0 | 165,704 | 215.7 K to 165.7 K (-23.18 %) |
Apr 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 4,475,191 | 6.5 M to 4.5 M (-30.89 %) |
Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 28.73 | 10,900 | 313,146 | 146,208 | 157.1 K to 146.2 K (-6.94 %) |
Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 27.69 | 7,279 | 201,526 | 157,108 | 164.4 K to 157.1 K (-4.43 %) |
Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 26.95 | 27,115 | 730,803 | 164,387 | 191.5 K to 164.4 K (-14.16 %) |
Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 25.50 | 1,000,000 | 25,500,000 | 285,713 | 1.3 M to 285.7 K (-77.78 %) |
Mar 06 2017 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 25.50 | 1,000,000 | 25,500,000 | 6,475,191 | 7.5 M to 6.5 M (-13.38 %) |
Dec 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 7,475,191 | 9.5 M to 7.5 M (-21.11 %) |
Nov 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 19.36 | 1,000,000 | 19,360,000 | 1,285,713 | 2.3 M to 1.3 M (-43.75 %) |
Nov 16 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 19.36 | 1,000,000 | 19,360,000 | 9,475,191 | 10.5 M to 9.5 M (-9.55 %) |
Nov 07 2016 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 10,475,191 | 12.5 M to 10.5 M (-16.03 %) |
Aug 19 2015 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 41,663,168 | 0 | 0 | |
Aug 19 2015 | GBT | Global Blood Thera ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 11,903,763 | 0 | 12,475,191 | 571.4 K to 12.5 M (+2,083.16 %) |
Page: 1